Form 4: Praxis GC Sells Shares for Tax Obligations

Praxis Precision Medicines' General Counsel, Alex Nemiroff, disposed of 768 common shares at $275.74 each to cover tax withholding obligations related to restricted stock unit vesting.

Summary

• Alex Nemiroff, General Counsel and Secretary of Praxis Precision Medicines, Inc. (PRAX), reported a transaction involving common stock.
• On January 12, 2026, Nemiroff disposed of 768 shares of common stock.
• The shares were disposed of at a price of $275.74 per share.
• This transaction was executed to satisfy tax withholding obligations in connection with the vesting of previously reported restricted stock units.
• Following this transaction, Nemiroff beneficially owns 25,932.667 shares of common stock directly.
• The transaction was made pursuant to a Rule 10b5-1 plan.

Sentiment

Score: 5

Explanation: The transaction is a routine, non-discretionary sale of shares to cover tax obligations upon RSU vesting, which is a neutral event for the company's operational performance or future prospects.

Positives

• The transaction indicates the vesting of restricted stock units, which is a form of employee compensation and retention.
• The transaction was made pursuant to a Rule 10b5-1 plan, demonstrating pre-planned and transparent insider trading practices.

Negatives

• A disposal of shares by an insider, even for tax purposes, reduces their direct ownership in the company.

Future Outlook

Not applicable, as Form 4 filings report past transactions and do not typically contain forward-looking statements or guidance.

Industry Context

Insider transactions, particularly those related to tax withholding on equity compensation, are common across all industries for publicly traded companies. This filing reflects a routine compliance event rather than a strategic industry development.

Corporate Governance

Related Party Transactions

• The disposal of shares by Alex Nemiroff, an officer of Praxis Precision Medicines, Inc., to the issuer for tax withholding purposes is a direct transaction between a related party (insider) and the company.

Stakeholder Impact

• Shareholders: Minimal impact, as it's a routine, non-discretionary tax-related sale by an insider, not indicative of a change in company fundamentals or management's confidence.
• Employees: The vesting of RSUs is a positive for the employee (Alex Nemiroff) as it represents realized compensation.

Key Dates

Recommendation

This Form 4 filing reports a routine, non-discretionary sale of shares by an insider to cover tax obligations upon the vesting of restricted stock units. Such transactions are common and generally do not reflect a change in the insider's confidence in the company or its fundamental outlook. Therefore, it does not warrant a change in investment recommendation based solely on this filing.

Keywords

Praxis Precision Medicines, PRAX, Alex Nemiroff, Form 4, insider transaction, stock sale, tax withholding, restricted stock units, corporate governance, Rule 10b5-1